Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2009 1
2010 1
2012 2
2013 4
2014 2
2015 2
2016 3
2017 4
2018 7
2019 9
2020 11
2021 13
2022 13
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Treatment of actinic keratosis: a systematic review.
Worley B, Harikumar V, Reynolds K, Dirr MA, Christensen RE, Anvery N, Yi MD, Poon E, Alam M. Worley B, et al. Arch Dermatol Res. 2023 Jul;315(5):1099-1108. doi: 10.1007/s00403-022-02490-5. Epub 2022 Dec 1. Arch Dermatol Res. 2023. PMID: 36454335 Review.
Treatment of actinic keratoses (AKs) can help lower the risk of eventual skin cancer and address field pre-cancerization. This review compares the different therapeutic options for actinic keratosis. Databases used include Medline, EMBASE, Web of Science and the Coc …
Treatment of actinic keratoses (AKs) can help lower the risk of eventual skin cancer and address field pre-cancerization. This review compar …
Guidelines of care for the management of actinic keratosis.
Eisen DB, Asgari MM, Bennett DD, Connolly SM, Dellavalle RP, Freeman EE, Goldenberg G, Leffell DJ, Peschin S, Sligh JE, Wu PA, Frazer-Green L, Malik S, Schlesinger TE. Eisen DB, et al. J Am Acad Dermatol. 2021 Oct;85(4):e209-e233. doi: 10.1016/j.jaad.2021.02.082. Epub 2021 Apr 2. J Am Acad Dermatol. 2021. PMID: 33820677
Use of Topical Calcipotriol Plus 5-Fluorouracil in the Treatment of Actinic Keratosis: A Systematic Review.
Mohney L, Singh R, Grada A, Feldman S. Mohney L, et al. J Drugs Dermatol. 2022 Jan 1;21(1):60-65. doi: 10.36849/JDD.2022.6632. J Drugs Dermatol. 2022. PMID: 35005863
BACKGROUND: Actinic Keratosis (AK) is a premalignant lesion that can progress to cutaneous squamous cell carcinoma (cSCC). ...Studies that assess the use of calcipotriol and 5-FU to treat actinic keratosis (AK) and cSCC prevention were included. RESULT …
BACKGROUND: Actinic Keratosis (AK) is a premalignant lesion that can progress to cutaneous squamous cell carcinoma (cSCC). ... …
New Topical Treatment Options for Actinic Keratosis: A Systematic Review.
Stockfleth E, Sibbring GC, Alarcon I. Stockfleth E, et al. Acta Derm Venereol. 2016 Jan;96(1):17-22. doi: 10.2340/00015555-2167. Acta Derm Venereol. 2016. PMID: 26068001 Free article. Review.
This systematic review compared the relative efficacy of 5-fluorouracil 0.5% in salicylic acid 10% (5-FU/SA), ingenol mebutate (IMB) and imiquimod 2.5%/3.75% (IMI) for actinic keratosis on the face, forehead or scalp. Only 11 publications, relating to 7 randomised c …
This systematic review compared the relative efficacy of 5-fluorouracil 0.5% in salicylic acid 10% (5-FU/SA), ingenol mebutate (IMB) and imi …
Photodynamic therapy and pain: A systematic review.
Ang JM, Riaz IB, Kamal MU, Paragh G, Zeitouni NC. Ang JM, et al. Photodiagnosis Photodyn Ther. 2017 Sep;19:308-344. doi: 10.1016/j.pdpdt.2017.07.002. Epub 2017 Jul 15. Photodiagnosis Photodyn Ther. 2017. PMID: 28716738 Review.
Evidence-Based Clinical Practice Guidelines for Laser-Assisted Drug Delivery.
Labadie JG, Ibrahim SA, Worley B, Kang BY, Rakita U, Rigali S, Arndt KA, Bernstein E, Brauer JA, Chandra S, Didwania A, DiGiorgio C, Donelan M, Dover JS, Galadari H, Geronemus RG, Goldman MP, Haedersdal M, Hruza G, Ibrahimi OA, Kauvar A, Kelly KM, Krakowski AC, Miest R, Orringer JS, Ozog DM, Ross EV, Shumaker PR, Sobanko JF, Suozzi K, Taylor MB, Teng JMC, Uebelhoer NS, Waibel J, Wanner M, Ratchev I, Christensen RE, Poon E, Miller CH, Alam M. Labadie JG, et al. JAMA Dermatol. 2022 Oct 1;158(10):1193-1201. doi: 10.1001/jamadermatol.2022.3234. JAMA Dermatol. 2022. PMID: 35976634
The key findings that informed the guidelines developed by the expert panel were as follows: LADD is safe in adults and adolescents (12 years) with all Fitzpatrick skin types and in patients with immunosuppression; it is an effective treatment for actinic keratosis, …
The key findings that informed the guidelines developed by the expert panel were as follows: LADD is safe in adults and adolescents (12 year …
The Role of Nicotinamide as Chemo-Preventive Agent in NMSCs: A Systematic Review and Meta-Analysis.
Tosti G, Pepe F, Gnagnarella P, Silvestri F, Gaeta A, Queirolo P, Gandini S. Tosti G, et al. Nutrients. 2023 Dec 27;16(1):100. doi: 10.3390/nu16010100. Nutrients. 2023. PMID: 38201930 Free PMC article. Review.
Nicotinamide has been widely studied as a safe chemopreventive agent that reduces actinic keratosis (AKs) and non-melanoma skin cancers (NMSC). METHODS: We used the Medline, EMBASE, PubMed, and Cochrane databases to search the concepts "nicotinamide", "chemopreventi …
Nicotinamide has been widely studied as a safe chemopreventive agent that reduces actinic keratosis (AKs) and non-melanoma ski …
Patient-reported outcomes of topical therapies in actinic keratosis: A systematic review.
Grada A, Feldman SR, Bragazzi NL, Damiani G. Grada A, et al. Dermatol Ther. 2021 Mar;34(2):e14833. doi: 10.1111/dth.14833. Epub 2021 Feb 21. Dermatol Ther. 2021. PMID: 33527673 Free PMC article. Review.
Patients' perspectives on actinic keratosis treatments may have an impact on treatment adherence and, therefore, therapeutic outcomes. ...The findings underscore the need for effective and well-tolerated, short-duration topical treatment for actinic kerato …
Patients' perspectives on actinic keratosis treatments may have an impact on treatment adherence and, therefore, therapeutic o …
Pharmacoeconomic Considerations in Treating Actinic Keratosis: An Update.
Vale SM, Hill D, Feldman SR. Vale SM, et al. Pharmacoeconomics. 2017 Feb;35(2):177-190. doi: 10.1007/s40273-016-0462-4. Pharmacoeconomics. 2017. PMID: 27785771 Review.
Actinic keratosis is one of the most common dermatological diagnoses worldwide, especially among the elderly, fair-skinned, and immunocompromised, and is associated with a risk of transformation to skin cancer. With actinic keratosis and skin cancer pr …
Actinic keratosis is one of the most common dermatological diagnoses worldwide, especially among the elderly, fair-skinned, an …
68 results